Implementation and early clinical results utilizing Cs-131 permanent interstitial implants for gynecologic malignancies

Charles Eric Wooten, Marcus Randall, Jason Edwards, Prakash Aryal, Wei Luo, Jonathan Feddock

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Objective Permanent interstitial brachytherapy is an ideal yet underutilized treatment modality for accessible, small volume gynecological malignancies. We present early clinical results utilizing a new permanent isotope, Cs-131. Methods A retrospective review was performed evaluating patients treated with Cs-131 permanent interstitial radiation at our institution from July 2011 through June 2013. Doses were most commonly prescribed and calculated to a depth of 5 mm using Paterson-Parker planar implant rules for Au-198. This activity was converted to air-kerma strength (U). A conversion factor of 1.1 was applied based on RBE calculations, clinical observation and experience. Results 14 patients were identified among whom 17 Cs-131 implants were performed. Seven patients were implanted as sole therapy, and a median dose of 50 Gy was delivered. Ten implants were performed as boost within a more extensive radiation treatment plan. In these patients, a median implant dose of 27.5 Gy was used and the median total dose delivered in combination was 78.25 Gy. After a median follow up of 12 months, the actuarial local control rate was 84.4%. A very low level of grade 1-3 reactions was observed with no fistula formations or other severe side effects. Conclusions Permanent interstitial brachytherapy with Cs-131 was well tolerated with favorable early results compared to other series. Cs-131 has multiple favorable properties, including minimal radiation exposure to treating staff, and should be considered as a therapeutic option in appropriately selected patients. A methodology for dose prescription, calculation of radioactivity required and distribution of the isotope is also presented.

Original languageEnglish
Pages (from-to)268-273
Number of pages6
JournalGynecologic Oncology
Issue number2
StatePublished - May 2014


  • Brachytherapy
  • Cs-131
  • Gynecologic cancer
  • Interstitial radiation
  • Radiation implant
  • Re-irradiation

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology


Dive into the research topics of 'Implementation and early clinical results utilizing Cs-131 permanent interstitial implants for gynecologic malignancies'. Together they form a unique fingerprint.

Cite this